Professional Documents
Culture Documents
16. Wuhrman Elsa, Maureen F, Cooney, et al. Acute Pain: Assessment and
Treatment. Topics in Advanced Practice Nursing Ejournal[Internet].
2011[cited 2014 Jan 30]. Available from: http://www.medscape.com/
viewarticle/735034_3
17. NB Patel. Physiology of Pain. In: Guide to Pain Management in Low
Resources Setting. IASP 2010.[cited 2014 Jan 2]; 13-7. Available from:
https://www.uonbi.ac.ke/npatel/files/chapter_3_physiology_of_pain_.pdf
18. GG Graham, Scott KF. Mechanism of Action of Paracetamol. Am J
Ther [Internet]. 2005[cited 2014 jan 30]; 12(1): 46-55. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/15662292
19. MP Jensen, Chen C, Brugger AM. Interpretation of Visual Analog Scale
Ratings and Change Scores: a Reanalysis of Two Clinical Trials of
Postoperative Pain. J Pain [Internet]. 2003.[cited 2014 Jan 30]; 4(7): 407-
414. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14622683
20. De Benedittis G , Lorenzetti A, Migliore M, Spagnoli D, Tiberio F, Villani
RM. Postoperative Pain In Neurosurgery: A Pilot Study In Brain Surgery.
Neurosurgery[Internet].1996.[cited 2014 Jan 2]; 38(3): 469-470. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/8837797
21. De Gray L.C., B.F. Matta. Acute and Chronic Pain Following Craniotomy:
a Review. Anaesthesia[Internet]. 2005. [cited 2014 Jan 2]; 60(7): 693-704.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/15960721
22. Pubchem Choumpound. Fentanyl. [cited 2014 Jan 31]. Available from:
http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=3345
60
23. Hartono Ruddi, Wiwi Jaya, Djudjuk Rahmad Basuki. Pengaruh Pemberian
Fentanyl 1µg/Kgbb Sebagai Ajuvan pada Bupivacain 0,5% Terhadap
Onset Blok Motorik dan Sensorik Pasie yang Dilakukan Anestesi
Epidural. Jurnal Anestesi Indonesia. 2013.[cited 2014 Jan 2] ;5(1).
Available from: www.janesti.com/journal/view/article/87
24. Tan I. Farmakologi dan Terapi.Jakarta: Balai Penerbit FKUI, 2007.
25. Chahl, Loris A. Opioid-mechanism of action. Australian Prescriber. 1996
[cited 2014 Jan 25]; 19: 63-65.Available from: http://www.
australianprescriber.com/magazine/19/3/63/5
26. Katzung Bertram G. Farmakologi Dasar & Klinik, 10th ed. Jakarta: EGC;
2007.
27. Gupta Anuj, Kirtipal Kaur, Sheeshpal Sharma, Shubham Goyal, Saahil
Arora, R.S.R Murthy. Clinical Aspect of Acute Post-Operative Pain
Management & Its Assesment. Journal of Advance Pharmacology
Technology and Research. 2010.[cited 2014 Jan 2]; 1(2): 102. Available
from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255434/
28. Viscusi, Eugene R. IV Acetaminophen Improves Pain Management and
Reduces Opioid Requirements in Surgical Patients: A review of the
clinical Data and Case-based Presentation. Anesthesiology News. 2012.
[cited 2014 Jan 20]; Available from : http://www. painmedicinenews.com
/download/SR122_WM.pdf
29. DE, Feierman. The effect of paracetamol (acetaminophen) on fentanyl
metabolism in vitro. Acta Anaesthesiol Scand. 2000.[cited 2014 Jan 29];
44(5):560-563. Available from: http://www.ncbi.nlm.nih.gov/pubmed/
10786743
30. DJ Kehlet H. Anesthesia for Caesarean Delivery. Anesth Anelg. 1993.
[cited 2014 Jan 30]; 77:1048-1056. Available from: http://
www.medscape.org/viewarticle/581948
61
31. William. Effect of Intravenous Parecoxib on Post-craniotomy Pain. Br J
Anaesth. 2011. [cited 2014 June 14]; 107(3):398-403. Available from: http
://www.ncbi.nlm.nih.gov/pubmed/21841050
62
LAMPIRAN
Berikut ini naskah yang akan dibacakan pada Responden / Ibu Responden
Penelitian :
(a.I. berisi penjelasan apa yang akan dialami oleh responden diwawancarai)
Yth Bapak/Ibu :
Peneliti yang tersebut diatas adalah Mahasiswa Fakultas Kedokteran Universitas
Diponegoro yang bermaksud ingin menggunakan data rekam medik dalam
peneitian ini dengan tujuan mengetahui pengaruh pemberianm parasetamol 1000
mg intravena perioperatif terhadap penggunaan fentanyl pada pasien kraniotomi
di RSUP Dr. Kariadi Semarang. Peneliti akan mengambil data identitas,
kebutuhan fentanyl yang diperlukan selama operasi, skor visual analog scale,
serta kejadian mual muntah yang terjadi pada pasien tersebut. Peneliti menjamin
kerahasiaan identitas dan informasi yang diberikan. Informasi tersebut hanya
digunakan untuk kepentingan penelitian. Bapak/ Ibu berhak menolak dan
keluardari penelitian sesuai dengan keinginan.
Terima kasih atas kerjasama Bapak/Ibu/Sdr.
63
Setelah mendengar dan memahami penjelasan penelitian, dengan ini saya
menyatakan
Semarang,………………..... 2014
64
Lampiran 2. Ethical clearance
65
Lampiran 3. Surat ijin penelitian
66
Lampiran 4. Laporan Tindakan Anestesi
67
68
Lampiran 6. Lembar Evaluasi
69
70
Lampiran 6. Data SPSS
Crosstabs
Kelompok
Kontrol Perlakuan Total
Jenis kelamin Laki-laki Count 7 6 13
Expected Count 6.5 6.5 13.0
% within Kelompok 35.0% 30.0% 32.5%
% of Total 17.5% 15.0% 32.5%
Perempuan Count 13 14 27
Expected Count 13.5 13.5 27.0
% within Kelompok 65.0% 70.0% 67.5%
% of Total 32.5% 35.0% 67.5%
Total Count 20 20 40
Expected Count 20.0 20.0 40.0
% within Kelompok 100.0% 100.0% 100.0%
% of Total 50.0% 50.0% 100.0%
Chi-Square Tests
71
Umur
Case Summaries
Umur
Kelompok N Mean Std. Deviation Median Minimum Maximum
Kontrol 20 38.90 12.208 35.00 18 57
Perlakuan 20 43.20 12.792 44.50 15 72
Total 40 41.05 12.533 41.00 15 72
Tests of Normality
a
Kolmogorov-Smirnov Shapiro-Wilk
Kelompok Statistic df Sig. Statistic df Sig.
Umur Kontrol .156 20 .200* .924 20 .120
Perlakuan .113 20 .200* .980 20 .931
*. This is a lower bound of the true significance.
a. Lilliefors Significance Correction
80
25
60
Umur
40
20
35
Kontrol Perlakuan
Kelompok
72
T-Test
Group Statistics
Std. Error
Kelompok N Mean Std. Deviation Mean
Umur Kontrol 20 38.90 12.208 2.730
Perlakuan 20 43.20 12.792 2.860
Umur
Equal variances Equal variances
assumed not assumed
Levene's Test for F .227
Equality of Variances Sig. .636
t-test for Equality of t -1.088 -1.088
Means df 38 37.917
Sig. (2-tailed) .284 .284
Mean Difference
-4.300 -4.300
73
Lama operasi
Case Summaries
Lama operasi
Kelompok N Mean Std. Deviation Median Minimum Maximum
Kontrol 20 279.00 75.457 285.00 150 420
Perlakuan 20 300.00 97.939 300.00 165 480
Total 40 289.50 86.948 300.00 150 480
Tests of Normality
a
Kolmogorov-Smirnov Shapiro-Wilk
Kelompok Statistic df Sig. Statistic df Sig.
Lama operasi Kontrol .158 20 .200* .940 20 .236
Perlakuan .180 20 .089 .919 20 .095
*. This is a lower bound of the true significance.
a. Lilliefors Significance Correction
500
400
Lama operasi
300
200
100
Kontrol Perlakuan
Kelompok
74
T-Test
Group Statistics
Std. Error
Kelompok N Mean Std. Deviation Mean
Lama operasi Kontrol 20 279.00 75.457 16.873
Perlakuan 20 300.00 97.939 21.900
Lama operasi
Equal variances Equal variances
assumed not assumed
Levene's Test for F 2.396
Equality of Variances Sig. .130
t-test for Equality of t -.760 -.760
Means df 38 35.679
Sig. (2-tailed) .452 .452
Mean Difference
-21.000 -21.000
75
Kelompok
Case Summaries
Tests of Normality
a
Kolmogorov-Smirnov Shapiro-Wilk
Kelompok Statistic df Sig. Statistic df Sig.
VAS.1 Kontrol .283 20 .000 .845 20 .004
Perlakuan .269 20 .001 .815 20 .001
VAS.24 Kontrol .372 20 .000 .728 20 .000
Perlakuan .250 20 .002 .839 20 .003
a. Lilliefors Significance Correction
76
VAS.1
3
VAS.1
Kontrol Perlakuan
Kelompok
VAS.24
16
3
11
2.5
2
VAS.24
1.5
1 4
1
3 10
0.5
Kontrol Perlakuan
Kelompok
77
Kontrol
NPar Tests
Ranks
Test Statisticsb
VAS.24 -
VAS.1
Z -1.877a
Asymp. Sig. (2-tailed) .061
a. Based on positive ranks.
b. Wilcoxon Signed Ranks Test
78
Perlakuan
NPar Tests
Ranks
Test Statisticsb
VAS.24 -
VAS.1
Z -1.026a
Asymp. Sig. (2-tailed) .305
a. Based on positive ranks.
b. Wilcoxon Signed Ranks Test
79
NPar Tests
Mann-Whitney Test
Ranks
Test Statisticsb
VAS.1 VAS.24
Mann-W hitney U 96.500 87.000
Wilcoxon W 306.500 297.000
Z -2.906 -3.239
Asymp. Sig. (2-tailed) .004 .001
Exact Sig. [2*(1-tailed a a
.004 .002
Sig.)]
a. Not corrected for ties.
b. Grouping Variable: Kelompok
80
Kelompok
Case Summaries
Delta VAS
Kelompok N Mean Std. Deviation Median Minimum Maximum
Kontrol 20 -.60 1.314 .00 -3 2
Perlakuan 20 -.25 1.020 .00 -3 1
Total 40 -.43 1.174 .00 -3 2
Tests of Normality
a
Kolmogorov-Smirnov Shapiro-Wilk
Kelompok Statistic df Sig. Statistic df Sig.
Delta VAS Kontrol .226 20 .009 .930 20 .155
Perlakuan .297 20 .000 .847 20 .005
a. Lilliefors Significance Correction
Delta VAS
0
Delta VAS
-1
-2
27
-3
Kontrol Perlakuan
Kelompok
81
NPar Tests
Mann-Whitney Test
Ranks
Test Statisticsb
Delta VAS
Mann-Whitney U 165.500
Wilcoxon W 375.500
Z -.986
Asymp. Sig. (2-tailed) .324
Exact Sig. [2*(1-tailed a
.355
Sig.)]
a. Not corrected for ties.
b. Grouping Variable: Kelompok
Fentanyl
Case Summaries
Fentanyl
Kelompok N Mean Std. Deviation Median Minimum Maximum
Kontrol 20 201.25 67.119 200.00 100 350
Perlakuan 20 185.00 96.108 175.00 100 400
Total 40 193.13 82.234 200.00 100 400
Tests of Normality
a
Kolmogorov-Smirnov Shapiro-Wilk
Kelompok Statistic df Sig. Statistic df Sig.
Fentanyl Kontrol .207 20 .024 .926 20 .129
Perlakuan .212 20 .019 .821 20 .002
a. Lilliefors Significance Correction
82
400
350
300
Fentanyl
250
200
150
100
Kontrol Perlakuan
Kelompok
83
NPar Tests
Mann-Whitney Test
Ranks
Test Statisticsb
Fentanyl
Mann-Whitney U 161.000
Wilcoxon W 371.000
Z -1.087
Asymp. Sig. (2-tailed) .277
Exact Sig. [2*(1-tailed a
.301
Sig.)]
a. Not corrected for ties.
b. Grouping Variable: Kelompok
84
Mual muntah
Case Summaries
Mual muntah
Kelompok N Mean Std. Deviation Median Minimum Maximum
Kontrol 20 .30 .657 .00 0 2
Perlakuan 20 .00 .000 .00 0 0
Total 40 .15 .483 .00 0 2
Tests of Normalityb
a
Kolmogorov-Smirnov Shapiro-Wilk
Kelompok Statistic df Sig. Statistic df Sig.
Mual muntah Kontrol .476 20 .000 .515 20 .000
a. Lilliefors Significance Correction
b. Mual muntah is constant when Kelompok = Perlakuan. It has been omitted.
2
2
16
1.5
Mual muntah
76
1
0.5
Kontrol Perlakuan
Kelompok
85
NPar Tests
Mann-Whitney Test
Ranks
Test Statisticsb
Mual muntah
Mann-Whitney U 160.000
Wilcoxon W 370.000
Z -2.079
Asymp. Sig. (2-tailed) .038
Exact Sig. [2*(1-tailed a
.289
Sig.)]
a. Not corrected for ties.
b. Grouping Variable: Kelompok
86
Lampiran 7. Dokumentasi
87
Lampiran 8. Biodata mahasiswa
BIODATA MAHASISWA
88